What This Top Dividend Portfolio Is Holding Now: HSBC Holdings plc, GlaxoSmithKline plc And Centrica PLC

HSBC Holdings plc (LON:HSBA), GlaxoSmithKline plc (LON:GSK) and Centrica PLC (LON:CNA) are top dividend holdings of Murray Income Trust plc (LON:MUT).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

hsbcMurray Income Trust (LSE: MUT) announced its annual results last month, and delivered “the 40th consecutive year of annual dividend increases”. At a current share price of 704p, the trust yields 4.4%.

Picking great dividend shares has helped Murray Income outperform the FTSE All-Share Index over the past three, five and 10 years.

Let’s take a look at the three highest yielding stocks in Murray’s top 10 holdings: namely, HSBC (LSE: HSBA) (NYSE: HSBC.US), GlaxoSmithKline (LSE: GSK) and Centrica (LSE: CNA).

HSBC

HSBC, which came through the financial crisis better than many of its rivals, is ahead of the field in cleaning up its balance sheet, and is probably one of the most investible banks in Europe.

HSBC has averaged annual dividend growth in high single digits since 2009, and analysts are forecasting more of the same to come.

The company offers a significantly higher income than its peers — an income that’s recently become even more attractive. HSBC’s shares have dropped 8% over the last four weeks, pushing the 12-month forward yield up to 5.5% at a current price of 612p.

HSBC not only beats its banking rivals on yield, but also trounces the 3.5% on offer from the wider market.

GlaxoSmithKline

GlaxoSmithKline is in the midst of a bribery scandal. It isn’t the first company to face this kind of situation, and it won’t be the last. If history is any guide, there should be little long-term damage to the company.

Glaxo has averaged annual mid-single-digits dividend growth for shareholders since 2009. Analysts see this continuing, albeit at the lower end of the mid-single-digits range.

While the UK’s top pharmaceuticals group is set to deliver lesser income growth than HSBC in the immediate future, the starting yield is significantly higher than the bank’s: Glaxo offers 6.3% at a current share price of 1,304p.

Like HSBC, Glaxo is the leader for yield within its sector.

Centrica

The UK’s ‘Big Six’ energy companies — which include Centrica, the owner of British Gas — are under intense political and regulatory scrutiny at the moment. Utilities tend to go through such periods from time to time … but come out of the other side still delivering for shareholders.

Centrica was posting double-digits dividend growth five years ago. This subsequently moderated to mid single digits, and analysts see a further softening to low single digits growth for this year and next.

The political pressure on the energy firms of late and the recent broad stock market sell-off mean Centrica’s shares are trading at a 52-week low of 281p, giving a Glaxo-matching 12-month forward yield of 6.3%.

And once again, like Glaxo and HSBC, Centrica is the top stock within its sector for yield.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »